Browsing by Author Kaye, S. B.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 6 of 6
TitleAuthor(s)Issue date???itemlist.???
Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group StudySternberg, C. N.; ten Bokkel Huinink, W. W.; Smyth, J. F.; Bruntsch, V.; Dirix, L. Y.; Pavlidis, N. A.; Franklin, H.; Wanders, S.; Le Bail, N.; Kaye, S. B.24-Nov-2015-
Improved prognosis of patients with intermediate- and poor-risk nonseminomatous germ cell tumours by optimizing combined treatmentPentheroudakis, G.; De Bono, J. S.; Kaye, S. B.; Simpson, A.; Paul, J.; Brown, I.; Pamenter, B.; Kirk, A.; Vasey, P.; Raby, N.; Kirk, D.24-Nov-2015-
Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials GroupHanauske, A. R.; Catimel, G.; Aamdal, S.; ten Bokkel Huinink, W.; Paridaens, R.; Pavlidis, N.; Kaye, S. B.; te Velde, A.; Wanders, J.; Verweij, J.24-Nov-2015-
Phase II studies of Elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer and ovarian cancer. EORTC Early Clinical Trials GroupVerweij, J.; Wanders, J.; Nielsen, A. L.; Pavlidis, N.; Calabresi, F.; ten Bokkel Huinink, W.; Bruntsch, U.; Piccart, M.; Franklin, H.; Kaye, S. B.24-Nov-2015-
Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studiesSchellens, J. H.; Heinrich, B.; Lehnert, M.; Gore, M. E.; Kaye, S. B.; Dombernowsky, P.; Paridaens, R.; van Oosterom, A. T.; Verweij, J.; Loos, W. J.; Calvert, H.; Pavlidis, N.; Cortes-Funes, H.; Wanders, J.; Roelvink, M.; Sessa, C.; Selinger, K.; Wissel, P. S.; Gamucci, T.; Hanauske, A. R.24-Nov-2015-
Spontaneous acute tumour lysis syndrome in patients with metastatic germ cell tumours. Report of two casesPentheroudakis, G.; O'Neill, V. J.; Vasey, P.; Kaye, S. B.24-Nov-2015-